The Challenge. The Evidence. The Solution. Ventilator Associated Pneumonia (VAP) remains a serious clinical issue in UK ICUs with NHS England data estimating 3,0006,000 deaths per year and treatment costs of 10,00020,000 Management of VAP Caused by Multidrug Resistant Pathogens Page 3 Ventilator Associated Pneumonia (VAP) Prevention Bundle For Mechanically Ventilated Patient (MVP) By Comprehensive Unit based Safety Program (CUSP) Method Developed by: Agency for Healthcare Hassan A. Shaaban 2024 Year in Review: Ventilator Associated Pneumonia Brian J. Ring, 2025 Ventilator associated pneumonia biomarker evaluation (VIBE) study: protocol for a prospective, observational, case cohort study BMJ Open What is ventilator associated pneumonia? Medtecs Group